Nrf2 Deficiency Aggravates PM-induced Cardiomyopathy by Enhancing Oxidative Stress, Fibrosis and Inflammation Via RIPK3-regulated Mitochondrial Disorder
Overview
Affiliations
PM is a well-known air pollutant threatening public health, and long-term exposure to PM increases the risk of cardiovascular diseases. Nrf2 plays a pivotal role in the amelioration of PM-induced lung injury. However, if Nrf2 is involved in PM-induced heart injury, and the underlying molecular mechanisms have not been explored. In this study, wild type (Nrf2) and Nrf2 knockout (Nrf2) mice were exposed to PM for 6 months. After PM exposure, Nrf2 mice developed severe physiological changes, lung injury and cardiac dysfunction. In the PM-exposed hearts, Nrf2 deficiency caused significant collagen accumulation through promoting the expression of fibrosis-associated signals. Additionally, Nrf2 mice exhibited greater oxidative stress in cardiac tissues after PM exposure. Furthermore, PM-induced inflammation in heart samples were accelerated in Nrf2 mice through promoting inhibitor of α/nuclear factor κB (IκBα/NF-κB) signaling pathways. We also found that Nrf2 aggravated autophagy initiation and glucose metabolism disorder in hearts of mice with PM challenge. Cardiac receptor-interacting protein kinase 3 (RIPK3) expression triggered by PM was further enhanced in mice with the loss of Nrf2. Collectively, these results suggested that strategies for enhancing Nrf2 could be used to treat PM-induced cardiovascular diseases.
Yu Z, Xu C, Song B, Zhang S, Chen C, Li C J Transl Med. 2023; 21(1):708.
PMID: 37814303 PMC: 10563272. DOI: 10.1186/s12967-023-04554-0.
Park S, Lee H, Jeong H, Lee J, Cha H, Kim C Int J Mol Sci. 2023; 24(17).
PMID: 37686124 PMC: 10487650. DOI: 10.3390/ijms241713320.
Nrf2 regulated lung DNA demethylation and DNA methylation under PM exposure.
Wu M, Jiang M, Ding H, Tang S, Li D, Pi J Front Genet. 2023; 14:1144903.
PMID: 37113990 PMC: 10128193. DOI: 10.3389/fgene.2023.1144903.
Duality of Nrf2 in iron-overload cardiomyopathy.
Federti E, Vinchi F, Iatcenko I, Ghigo A, Matte A, Toya S Haematologica. 2023; 108(5):1335-1348.
PMID: 36700398 PMC: 10153524. DOI: 10.3324/haematol.2022.281995.
Wu X, Wei J, Yi Y, Gong Q, Gao J Front Pharmacol. 2022; 13:1057918.
PMID: 36569290 PMC: 9772885. DOI: 10.3389/fphar.2022.1057918.